Bradford Smith became the third patient to test Elon Musk's Neuralink — and the first one to do so without a voice.

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) ...

Reduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). Surprisingly, the protein shortage ...

As we move deeper into may, the East Texas harvest season will begin to show, whether its a bumper crop or a ‘break even’ season.

Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball ...

Jeffrey Lee Sharp, 62, faced trial on Monday in Judge R. Scott McKee’s courtroom and was convicted by a jury on Tuesday despite pleading not guilty.

Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...

The approved ALS therapy Radicava may cause serious unexpected side effects, such as liver problems and blood clots, per U.S.

STATEN ISLAND, N.Y. — Robert Moffit, a lifelong Staten Island resident who became an advocate for New York’s Medical Aid in ...

Eli Lilly (LLY) inks a licensing agreement with Alchemab to jointly develop an ALS drug in a $415M deal. Read more here.

Houston mortgage duo Cissy and Christopher Larkin are channeling a four-year ALS battle into a widespread fundraiser.

A special art tour program at the Virginia Museum of Fine Arts is bringing light and connection to people living with ALS and ...